Therini Bio

BiotechnologySeries ASacramento, UStherinibio.com

Latest round

Series A

Last raised

May 2025

Total raised

$101M

Investors

10

About Therini Bio

, is a biotechnology company that offers treatments to protect the nervous system from multiple sclerosis damage. The company was founded by Katerina Akassoglou. In April 2023, Therini Bio, Inc.75 million post-money. In May 2025, Therini Bio, Inc. Therini Bio develops novel therapies, mainly fibrin-targeted therapies and immunotherapies for neurological and inflammatory diseases such as Alzheimer’s disease (AD) and multiple sclerosis (MS). The firm’s pipeline product line includes THN391, systemic, a drug candidate for Alzheimer’s disease; THN39, IVT, a drug candidate for diabetic macular edema (DME); and bispecific fibrin/VEGF, a drug candidate for diabetic macular edema (DME). The company's research targets and attaches antibodies to fibrin without affecting critical clotting functions.

Who invested in Therini Bio

10 investors across 5 rounds

See all investors in Therini Bio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    May 14, 2025

    Amount

    $39M

    Investors

    Locked

  2. Series A

    Apr 27, 2023

    Amount

    $36M

    Investors

    Locked

  3. Seed

    May 10, 2021

    Amount

    $17M

    Investors

    Locked

  4. Seed

    May 15, 2020

    Amount

    $7M

    Investors

    Locked

  5. Seed

    May 8, 2019

    Amount

    $2.4M

    Investors

    Locked

Questions about Therini Bio

Who invested in Therini Bio?

Therini Bio has 10 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Therini Bio raised?

Therini Bio has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did Therini Bio last raise money?

Therini Bio's most recent round on record is a Series A, in May 2025.

What does Therini Bio do?

, is a biotechnology company that offers treatments to protect the nervous system from multiple sclerosis damage.

Where is Therini Bio headquartered?

Therini Bio is headquartered in Sacramento, US.

Which VCs invest in companies like Therini Bio?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Therini Bio's stage. Their profiles are linked below.

Raising like Therini Bio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.